A Trial to Learn if Single Ascending Intravenous (IV) Doses of REGN7508 Are Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants

NCT05603195 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: REGN7508 (IV)
DRUG: REGN7508 (SC)
DRUG: Matching Placebo (IV)
DRUG: Matching Placebo (SC)

Sponsor

Regeneron Pharmaceuticals